Targeted therapy in hormone refractory prostate cancer

被引：0
|
作者：
S. Burbridge
S. Chowdhury
P. G. Harper
机构：
[1] Guy’s Hospital London,Medical Oncology
来源：
Targeted Oncology | 2007年 / 2卷
关键词：
Hormone refractory prostate cancer; Docetaxel; Calcitriol; Angiogenesis; Endothelin-A antagonists; Imatinib; Erlotinib; Sunitinib; Pertuzumab; Matrix metalloproteinase inhibitors; Inhibitors of apoptosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Despite recent progress in the treatment of hormone refractory prostate cancer—with a survival advantage seen with docetaxel chemotherapy—there remains a need for further improvements in this important patient group. Novel targeted agents have promise both as single agents, and in combination with chemotherapy. However, further work is needed to identify therapeutic targets and to develop active agents with a view to introducing them into standard clinical practice.
引用
收藏
页码：235 / 240
页数：5
相关论文
共 50 条
  • [21] Lycopene: a novel drug therapy in hormone refractory metastatic prostate cancer
    Ansari, MS
    Gupta, NP
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2004, 22 (05) : 415 - 420
  • [22] Therapy of hormone refractory prostate cancer:: New standards, new trends
    Wülfing, C
    Bierer, S
    Bögemann, M
    Piechota, H
    Hertle, L
    AKTUELLE UROLOGIE, 2005, 36 (04) : 342 - 348
  • [23] Hormone refractory prostate cancer (HRPC): Present and future approaches of therapy
    Di Lorenzo, G
    De Placido, S
    INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, 2006, 19 (01) : 11 - 33
  • [24] Assessment of hormone refractory prostate cancer
    Newling, D
    Fossa, SD
    Andersson, L
    Abrahamsson, PA
    Aso, Y
    Eisenberger, MA
    Khoury, S
    Kozlowski, JS
    Kelly, K
    Scher, H
    HartleyAsp, B
    UROLOGY, 1997, 49 (4A) : 46 - 53
  • [25] Chemotherapy for hormone refractory prostate cancer
    Gridneva, Ya. V.
    Matveev, V. B.
    Bukharkin, B. V.
    Kupchan, D. Z.
    ONKOUROLOGIYA, 2010, 6 (04): : 54 - 60
  • [26] Hormone-refractory prostate cancer
    Alexandre, I.
    Rixe, O.
    ANNALES D UROLOGIE, 2007, 41 (02) : 47 - 55
  • [27] Chemotherapy of hormone refractory prostate cancer
    Wirth, MP
    Nippgen, J
    UROLOGE A, 2003, 42 (11): : 1453 - +
  • [28] Hormone refractory prostate cancer - Preface
    Pienta, KJ
    UROLOGIC CLINICS OF NORTH AMERICA, 1999, 26 (02) : XIII - XIII
  • [29] Hormone-Refractory prostate cancer
    Rini B.I.
    Small E.J.
    Current Treatment Options in Oncology, 2002, 3 (5) : 437 - 446
  • [30] The management of hormone refractory prostate cancer
    Newling, DWW
    EUROPEAN UROLOGY, 1996, 29 : 69 - 74
12345